Theragnostic Technologies Inc.

We develop multifunctional nanotechnology-based products for diagnostic, therapeutic & regenerative medicine. First product ManGraDex is MRI contrast agent.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Stony Brook, NY, US
  • Currency USD
  • Founded 2012
  • Employees 3
  • Website theragnostictechnologies.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free